Management of difficult, severe and recurrent Budd-Chiari syndrome.
- Author:
Zhong-gao WANG
1
;
Chun-min LI
;
Yong-quan GU
;
Heng-xi YU
;
Bing CHEN
;
Lian-rui GUO
;
Xue-feng LI
;
Shi-jun CUI
;
Zhen LI
Author Information
- Publication Type:Journal Article
- MeSH: Adolescent; Adult; Blood Vessel Prosthesis Implantation; Budd-Chiari Syndrome; surgery; Child; Child, Preschool; Critical Illness; Female; Follow-Up Studies; Humans; Male; Middle Aged; Portacaval Shunt, Surgical; Recurrence; Retrospective Studies; Treatment Outcome
- From: Chinese Journal of Surgery 2008;46(15):1149-1152
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo investigate the management of complicated, severe or recurrent Budd-Chiari syndrome.
METHODSFrom February 2004 to August 2007, 28 patients with complicated, severe or recurrent Budd-Chiari syndrome were treated. In this series, 16 patients relapsed after treated with percutaneous transluminal angioplasty or stent deployment, 2 cases relapsed after surgery; and the other 10 were under severe conditions and hard to treat, including malignancy of the inferior vena cava and right atrium. Meso-cavo-atrial shunt was carried out in 10 cases, meso-cavo-jugular shunt in 6 (capitis medusa was used in one case), cavoatrial shunt in 2 and cavo-jugular shunt in 1, mesocaval shunt in 2, and radical or extended radical correction in 7.
RESULTSOne patient (3.6%) died in 24 hours after operation. Graft infection occurred in 1 case. Excellent, good, fair, poor and death rate were 22.2%, 55.5%, 14.8%, 3.7% and 3.7%, respectively, the overall effective rate was 92.5%.
CONCLUSIONTo select personalized treatment according to the disease status brings hopes to difficult, severe, recurrent Budd-Chiari syndrome.
